Codi QR

Targeting Investigation and Treatment in Type 2 Myocardial Infarction

Background: Type 2 myocardial infarction occurs in the absence of atherothrombosis, due to myocardial oxygen supply or demand imbalance, often during another acute illness. It is common and associated with poor clinical outcomes. No randomized controlled trials are available to guide investigation o...

Descripció completa

Guardat en:
Autors principals: Caelan Taggart, MD, Amy Ferry, BSc, Stephanie Barker, BSc, Kelly Williams, BSc, Grace Souter, BSc, Anda Bularga, MD, Ryan Wereski, MD, Michael J. McDermott, MD, Michelle C. Williams, MD, PhD, Jasper Boeddinghaus, MD, Christopher White, BSc, Jagdeep S. Singh, MD, Keith Boath, BSc, Takeshi Fujisawa, PhD, Christopher Tuck, MSc, Anny Briola, MSc, Steff Lewis, PhD, Atul Anand, MD, PhD, Marc R. Dweck, MD, PhD, David E. Newby, MD, DSc, Rustam Al-Shahi Salman, MD, PhD, Nicholas L. Mills, MD, PhD, Andrew R. Chapman, MD, PhD
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2025-05-01
Col·lecció:JACC: Advances
Matèries:
coronary angiography
echocardiography
secondary prevention
type 2 myocardial infarction
universal definition
Accés en línia:http://www.sciencedirect.com/science/article/pii/S2772963X25001553
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars